Skip to main content

Advertisement

Table 4 Annual percentage change from baseline in tibial cartilage volume over 24 months

From: Safety, tolerability, clinical, and joint structural outcomes of a single intra-articular injection of allogeneic mesenchymal precursor cells in patients following anterior cruciate ligament reconstruction: a controlled double-blind randomised trial

  MPC + HA HA alone p*
Medial tibia
 6 months 0.7 (5.9) –4.0 (3.9) 0.10
 12 months 0.3 (6.3) –2.4 (3.1) 0.36
 24 months –1.4 (4.2) –3.3 (5.3) 0.54
Lateral tibia
 6 months –1.4 (5.3) –2.7 (4.4) 0.65
 12 months –4.7 (3.4) –2.6 (2.5) 0.25
 24 months –3.7 (3.4) –0.8 (3.5) 0.22
  1. Data are reported as mean (SD)
  2. * For difference between two groups using independent samples t test
  3. HA hyaluronan, MPC mesenchymal precursor cell